# Apixaban Versus Warfarin for Left Ventricular Thrombus

> **NCT07709780** · PHASE3 · RECRUITING · sponsor: **University of Arizona** · enrollment: 218 (estimated)

## Conditions studied

- Left Ventricular Thrombus

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT07709780
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-22
- **Primary completion:** 2028-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 218 (ESTIMATED)
- **Last updated:** 2026-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709780

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709780, "Apixaban Versus Warfarin for Left Ventricular Thrombus". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07709780. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*